UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn's disease

Expert review of gastroenterology & hepatology, 2023-06, Vol.17 (6), p.575-587

2023

Volltextzugriff (PDF)

P136 Blood-based biomarkers of type III collagen remodeling as surrogate markers of endoscopic disease activity in patients with Ulcerative Colitis

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i431-i432

2024

Volltextzugriff (PDF)

P384 Serum biomarkers of proteolytic type III and type IV collagen remodeling differentiate patients with Inflammatory Bowel Disease according to infliximab treatment response or non-response

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i806-i808

2024

Volltextzugriff (PDF)

P242 Immune-cell specific biomarker of early intestinal inflammation: Neutrophil elastase degraded fragment of type III collagen is elevated in patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i586-i588

2024

Volltextzugriff (PDF)

P127 Type I collagen degradation fragments (C1M) and human neutrophil elastase-derived fragments of calprotectin (CPa9-HNE) reflect biochemical and endoscopic disease activity in patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i214-i215

2022

Volltextzugriff (PDF)

P278 Type IV collagen formation/degradation ratio predicts response to infliximab induction therapy in patients with Ulcerative Colitis

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S309-S310

2021

Volltextzugriff (PDF)

P123 Type I collagen degradation fragments and type IV collagen formation/degradation ratio are serological biomarkers for stricturing (Montreal B2) Crohn’s disease

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S214-S215

2021

Volltextzugriff (PDF)

P308 CPa9-HNE: A NEUTROPHIL-DERIVED FRAGMENT OF CALPROTECTIN MEASURED IN SERUM CAN MONITOR ENDOSCOPIC AND CLINICAL DISEASE ACTIVITY IN ULCERATIVE COLITIS

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i687-i688

2024

Volltextzugriff (PDF)

P197 A biomarker of early mucosal destruction: Neutrophil-mediated type IV collagen degradation is elevated in patients with Crohn’s Disease and Ulcerative Colitis

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i349-i351

2023

Volltextzugriff (PDF)

P318 Protein FingerPrint assays reflecting neutrophil activity, mucosal damage, and tissue fibrosis are surrogate biomarkers for mucosal healing in pediatric Crohn’s disease

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i458-i459

2023

Volltextzugriff (PDF)

P509 Biomarkers of neutrophil activity and extracellular matrix turnover predict long-term response to vedolizumab in patients with Crohn’s disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i468-i469

2022

Volltextzugriff (PDF)

P611 Serological biomarkers of type VI and XXII collagen formation predict and monitor infliximab treatment response in patients with Crohn’s disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i541-i541

2022

Volltextzugriff (PDF)

P204 Endotrophin (PRO-C6) is associated with MRE confirmed intestinal strictures and Protein FingerPrint biomarkers of collagen degradation is associated with ulcerations in paediatric Crohn’s disease patients – results from the ImageKids study

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i264-i265

2022

Volltextzugriff (PDF)

P460 Biomarkers reflecting extracellular matrix turnover and inflammation can be used to monitor disease activity and treatment response in patients with Crohn’s disease undergoing infliximab induction therapy

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S453-S454

2021

Volltextzugriff (PDF)

P394 Serological biomarkers of type III and IV collagen remodeling predict and monitor infliximab treatment response in patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S403-S404

2021

Volltextzugriff (PDF)

Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn's Disease

International journal of molecular sciences, 2022-07, Vol.23 (15), p.8137

2022

Volltextzugriff (PDF)

The TGFβ Family in Human Placental Development at the Fetal-Maternal Interface

Biomolecules (Basel, Switzerland), 2020-03, Vol.10 (3), p.453

2020

Volltextzugriff (PDF)

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease

Alimentary pharmacology & therapeutics, 2022-08, Vol.56 (4), p.675-693

2022

Volltextzugriff (PDF)

Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease

Frontiers in medicine, 2022-07, Vol.9, p.933872-933872

2022

Volltextzugriff (PDF)

The TGF[beta] Family in Human Placental Development at the Fetal-Maternal Interface

Biomolecules (Basel, Switzerland), 2020-03, Vol.10 (3), p.1

2020

Volltextzugriff (PDF)

Mo1727 PROTEIN FINGERPRINT ASSAYS REFLECTING NEUTROPHIL ACTIVITY, MUCOSAL DAMAGE, AND TISSUE FIBROSIS ARE SURROGATE BIOMARKERS FOR MUCOSAL HEALING IN PEDIATRIC CROHN'S DISEASE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-882-S-882

2023

Volltextzugriff (PDF)

Tu1758 PRO-C11 AND PRO-C16 ARE MARKERS OF INTESTINAL FIBROSIS AND ARE ASSOCIATED WITH MRE-CONFIRMED INTESTINAL STRICTURES – RESULTS FROM THE IMAGEKIDS STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1409-S-1409

2024

Volltextzugriff (PDF)

Su1655: ENDOTROPHIN (PRO-C6) IS ASSOCIATED WITH MRE CONFIRMED INTESTINAL STRICTURES AND PROTEIN FINGERPRINT BIOMARKERS OF COLLAGEN DEGRADATION IS ASSOCIATED WITH ULCERATIONS IN PAEDIATRIC CROHN'S DISEASE PATIENTS – RESULTS FROM THE IMAGEKIDS STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-659-S-660

2022

Volltextzugriff (PDF)

Mo1524: SEROLOGICAL BIOMARKERS OF TYPE VI AND XXII COLLAGEN FORMATION PREDICT AND MONITOR INFLIXIMAB TREATMENT RESPONSE IN PATIENTS WITH CROHN’S DISEASE

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-803-S-803

2022

Volltextzugriff (PDF)

Su1526: TYPE I COLLAGEN DEGRADATION FRAGMENTS (C1M) AND HUMAN NEUTROPHIL ELASTASE-DERIVED FRAGMENTS OF CALPROTECTIN (CPA9-HNE) REFLECT BIOCHEMICAL AND ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-614-S-614

2022

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)
Buchkapitel
(3)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn's disease

P136 Blood-based biomarkers of type III collagen remodeling as surrogate markers of endoscopic disease activity in patients with Ulcerative Colitis

P384 Serum biomarkers of proteolytic type III and type IV collagen remodeling differentiate patients with Inflammatory Bowel Disease according to infliximab treatment response or non-response

P242 Immune-cell specific biomarker of early intestinal inflammation: Neutrophil elastase degraded fragment of type III collagen is elevated in patients with Inflammatory Bowel Disease

P127 Type I collagen degradation fragments (C1M) and human neutrophil elastase-derived fragments of calprotectin (CPa9-HNE) reflect biochemical and endoscopic disease activity in patients with Inflammatory Bowel Disease

P278 Type IV collagen formation/degradation ratio predicts response to infliximab induction therapy in patients with Ulcerative Colitis

P123 Type I collagen degradation fragments and type IV collagen formation/degradation ratio are serological biomarkers for stricturing (Montreal B2) Crohn’s disease

P308 CPa9-HNE: A NEUTROPHIL-DERIVED FRAGMENT OF CALPROTECTIN MEASURED IN SERUM CAN MONITOR ENDOSCOPIC AND CLINICAL DISEASE ACTIVITY IN ULCERATIVE COLITIS

P197 A biomarker of early mucosal destruction: Neutrophil-mediated type IV collagen degradation is elevated in patients with Crohn’s Disease and Ulcerative Colitis

P318 Protein FingerPrint assays reflecting neutrophil activity, mucosal damage, and tissue fibrosis are surrogate biomarkers for mucosal healing in pediatric Crohn’s disease

P509 Biomarkers of neutrophil activity and extracellular matrix turnover predict long-term response to vedolizumab in patients with Crohn’s disease

P611 Serological biomarkers of type VI and XXII collagen formation predict and monitor infliximab treatment response in patients with Crohn’s disease

P204 Endotrophin (PRO-C6) is associated with MRE confirmed intestinal strictures and Protein FingerPrint biomarkers of collagen degradation is associated with ulcerations in paediatric Crohn’s disease patients – results from the ImageKids study

P460 Biomarkers reflecting extracellular matrix turnover and inflammation can be used to monitor disease activity and treatment response in patients with Crohn’s disease undergoing infliximab induction therapy

P394 Serological biomarkers of type III and IV collagen remodeling predict and monitor infliximab treatment response in patients with Inflammatory Bowel Disease

Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn's Disease

The TGFβ Family in Human Placental Development at the Fetal-Maternal Interface

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease

Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease

The TGF[beta] Family in Human Placental Development at the Fetal-Maternal Interface

Mo1727 PROTEIN FINGERPRINT ASSAYS REFLECTING NEUTROPHIL ACTIVITY, MUCOSAL DAMAGE, AND TISSUE FIBROSIS ARE SURROGATE BIOMARKERS FOR MUCOSAL HEALING IN PEDIATRIC CROHN'S DISEASE

Tu1758 PRO-C11 AND PRO-C16 ARE MARKERS OF INTESTINAL FIBROSIS AND ARE ASSOCIATED WITH MRE-CONFIRMED INTESTINAL STRICTURES – RESULTS FROM THE IMAGEKIDS STUDY

Su1655: ENDOTROPHIN (PRO-C6) IS ASSOCIATED WITH MRE CONFIRMED INTESTINAL STRICTURES AND PROTEIN FINGERPRINT BIOMARKERS OF COLLAGEN DEGRADATION IS ASSOCIATED WITH ULCERATIONS IN PAEDIATRIC CROHN'S DISEASE PATIENTS – RESULTS FROM THE IMAGEKIDS STUDY

Mo1524: SEROLOGICAL BIOMARKERS OF TYPE VI AND XXII COLLAGEN FORMATION PREDICT AND MONITOR INFLIXIMAB TREATMENT RESPONSE IN PATIENTS WITH CROHN’S DISEASE

Su1526: TYPE I COLLAGEN DEGRADATION FRAGMENTS (C1M) AND HUMAN NEUTROPHIL ELASTASE-DERIVED FRAGMENTS OF CALPROTECTIN (CPA9-HNE) REFLECT BIOCHEMICAL AND ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Suchergebnisse filtern